PPARγ levels presented an increase in tumor tissue, which was also seen by DuBois et al. [38], that can be interpreted as an insufficient attempt of PPARγ to avoid IκB phosphorylation for maintaining NF-κB at the cytoplasm and decrease the inflammatory status. The gene discussed is NFKB1; the disease is neoplasm.